Abstract. Statins increase the production of nitric oxide (NO) and have beneficial effects on the course of acute renal failure (ARF) in young rats. The effects of a short-term treatment with atorvastatin (ATO) on ischemic ARF in old rats, characterized by a great susceptibility to ischemia, was tested. No difference was found in renal dynamics between young (Y, 3 mo old) and old (O, 18 mo old) rats in normal conditions (CON) or after ATO treatment (12 mg/kg/d for 14 d). Twenty-four hours after clamping of both renal arteries, a more pronounced decrease in GFR was observed in O rats versus Y rats after a greater renal vasoconstriction and hypoperfusion of aging animals. Pretreatment with ATO mitigated renal vasoconstriction in O rats and restored GFR values to Y rats. Nitrate excretion was enhanced in Y rats after ARF but was not further modified by ATO; in O rats, ARF did not increase nitrate excretion, which was raised after ATO treatment. This reflected the increase in endothelial NO synthase (eNOS)-mRNA expression and eNOS protein observed in old ATO-treated animals with ARF. ATO treatment had also a significant protective effect against the cell injury at tubular level in O, but not Y, rats. The Ras system was not influenced by ATO in O rats, whereas the activation of Rho proteins was partially inhibited by ATO. Low-dose treatment with ATO enhances NO availability in aging rats, improving renal dynamics and conferring a peculiar histologic protection at tubular level after ischemia.In most animal species, the aging process is associated with a peculiar predisposition to renal damage in response to drugs, altered salt metabolism, and ischemia (1,2). A previous study from our laboratory has shown that ischemic injury after renal arteries clamping determines a more pronounced decrease of renal plasma flow (RPF) and GFR in old (O) rats when compared with young (Y) rats (3). Renal impairment in aging rats, however, was partially blunted by the administration of oral supplements of either arginine, the precursor of nitric oxide (NO), or SOD, a scavenger of reactive oxygen species (ROS), clearly suggesting that an endothelial dysfunction, secondary to NO deficiency and increased ROS production, was the main factor responsible for the intense renal vasoconstriction of aging animals (3). Although that study raised the theoretical possibility that some unfavorable effects due to renal hypoperfusion in the elderly could be prevented, to date, there is no definitive evidence that a specific prophylactic treatment can reduce the occurrence of these events in aging, because the use of arginine as precursor of NO does not seem to be indicated in the elderly on the basis of the better knowledge of the metabolism of this amino acid and its possible side effects after oral administration (4).A recent study has shown that a 3-d treatment with a high dose of cerivastatin had beneficial effects in mitigating the course of ischemic acute renal failure (ARF) in young rats independent of their cholesterol levels (5). On this basis...